“Into Public Orbit”
We run through the equity plumbing behind the SpaceX IPO, and what the read-through could be for names like OpenAI and Anthropic when private-market AI valuations eventually make the jump into public markets.
https://t.co/FXeTcH9mXb
Naz down 3.8%, Spoos down 2.2%. Equity selloff elsewhere, especially Asia. Global large and mids down 2.1%
Rates-led de-risking session, heavy factor unwind underneath.
Slightly more of an opinion piece than a market memo today, but the underlying shift in crypto (formally the tip of the risk spear) is worth considering.
Free to read on our website.
https://t.co/uOJE39zPb4
…as an equity allocation. Seems a compelling area in pharma if the US keeps pushing for broader access to mental health treatments.
Maybe the “God Molecule” (5-MeO-DMT) trade is the GLP-1 trade for the mind. Atai Life Sciences bought Beckley Psytech last year to support late-stage trials.
Not a pharma guy, but it’s an interesting space to watch.